Latest Cancer: Bladder news
Cretostimogene Promising for High-Risk, Non-Muscle-Invasive Bladder Cancer
posted August 6th
by modernClinician Editorial Team
by modernClinician Editorial Team
Enfortumab Vedotin-Pembrolizumab More Effective for MIBC Than Cisplatin-Gemcitabine
posted July 28th
by modernClinician Editorial Team
by modernClinician Editorial Team
Perioperative Enfortumab Vedotin + Pembrolizumab Tied to Improved Outcomes With Bladder Cancer
posted February 27th
by modernClinician Editorial Team
by modernClinician Editorial Team
Color Vision Deficiency Associated With Shorter Survival for Patients With Bladder Cancer
posted January 20th
by modernClinician Editorial Team
by modernClinician Editorial Team
Editor's Recommendations
Organized, Biennial FIT-Based Screening Linked to Lower Colorectal Cancer Mortality 
Achieving PSA <0.2 ng/mL Improves Survival in Metastatic Castration-Sensitive Prostate Cancer 
Recurrence Score Elevated for Breast Cancer Diagnosed Within First Year Postpartum 
Lung Transplant Can Prolong Survival in Stage IV NSCLC 
Meta-Analysis IDs Link Between Type 1 Diabetes and Bladder Cancer 
Acute Cystitis Tied to Higher Risk for Urogenital Cancers Monthly Specialist Briefings
Stay Connected
